HekaFlo is an HFNC Device or a Respiratory support system for the treatment of spontaneously         breathing hypoxic patients with humidified and heated oxygen at a     flow rate from 2 to  60 LPM . This is world’s first IoT enabled HFNC Device with remote patient monitoring.

HFNC provides humidified, titrated oxygen therapy matching or even exceeding the patients' inspiratory demand.  This treatment is highly effective for patients with Post-COVID complications having difficulty in breathing or shortness of breath.

HFNC is an effective and safe initial respiratory support treatment in children less than two years with mild to moderate respiratory failure due to pneumonia.

High-Flow Nasal Cannula (HFNC) Treatment is a non-invasive respiratory support therapy that delivers warm, humidified, oxygen-enriched air to patients, usually using a nasal cannula. Typically used in spontaneously breathing patients who typically require oxygen at higher flow rates. It can provide respiratory support of patients with acute hypoxemic respiratory failure and prevent subsequent intubation when used correctly. This greatly enhances patient comfort and ease of use.

 Heka Medicals is awarded Indian Patent     under no. 431088 and recorded in the Register of Patents on 4th May 2023 for an invention entitled IOT ENABLED NOVEL HIGH FLOW NASAL OXYGEN DELIVERY SYSTEM in accordance with the provisions of the Patents Act,1970.

 Heka Medicals Is an ISO 13485 and ICMED 13485 certified company and also has received the CDSCO manufacturing license and Free sale Certificate for the product HekaFlo. HekaFlo is tested and conforming to  IEC 60601-1 and IEC 60601-1-2 

The proposed device consists of a main body which incorporates and blower with brushless DC motor and a blender to mix the Oxygen and Air which will be fed to a heated humidifier chamber which will supply the blended and heated gas to the patients using a special nasal tube and cannula.

The basic  components include a flow generator providing gas flow rates up to 60 liters per minute, an air-oxygen blender that achieves escalation of FIO2 from 21% to 100% irrespective of flow rates, and a humidifier that saturates the gas mixture at a temperature of 31 to 37 C. To minimize condensation, the heated humidified gas is delivered via heated tubing through a wide-bore nasal prong.